Cargando…
Evaluation of SARS-CoV-2 IgG antibody response in PCR positive patients: Comparison of nine tests in relation to clinical data
SARS-CoV-2 antibody tests are available in various formats, detecting different viral target proteins and antibody subclasses. The specificity and sensitivity of SARS-CoV-2 antibody tests are known to vary and very few studies have addressed the performance of these tests in COVID-19 patient groups...
Autores principales: | Naaber, Paul, Hunt, Kaidi, Pesukova, Jaana, Haljasmägi, Liis, Rumm, Pauliina, Peterson, Pärt, Hololejenko, Jelena, Eero, Irina, Jõgi, Piia, Toompere, Karolin, Sepp, Epp |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591045/ https://www.ncbi.nlm.nih.gov/pubmed/33108380 http://dx.doi.org/10.1371/journal.pone.0237548 |
Ejemplares similares
-
Prevalence of SARS-CoV-2 IgG antibodies and their association with clinical symptoms of COVID-19 in Estonia (KoroSero-EST-1 study)
por: Jõgi, Piia, et al.
Publicado: (2021) -
Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study
por: Naaber, Paul, et al.
Publicado: (2021) -
Long-Term Elevated Inflammatory Protein Levels in Asymptomatic SARS-CoV-2 Infected Individuals
por: Tserel, Liina, et al.
Publicado: (2021) -
Protective antibodies and T cell responses to Omicron variant after the booster dose of BNT162b2 vaccine
por: Naaber, Paul, et al.
Publicado: (2022) -
Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19
por: Haljasmägi, Liis, et al.
Publicado: (2020)